REQUEST A DEMO
Total
USD $0.00
Search more companies

Miroslawa Frankowska-Majchrzak I Anna Galica sp. j. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Miroslawa Frankowska-Majchrzak I Anna Galica sp. j. Profile Updated: October 25, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Miroslawa Frankowska-Majchrzak I Anna Galica sp. j. is an enterprise in Poland, with the main office in Nowy Targ. The company operates in the Ambulatory Health Care Services sector. The company was established on October 02, 2006. In its most recent financial highlights, the company reported a net sales revenue increase of 5.45% in 2024. Over the same period, its total assets decreased by 39.2%. The net profit margin of Miroslawa Frankowska-Majchrzak I Anna Galica sp. j. decreased by 21.8% in 2024.

Headquarters
Ul. Os. W. Witosa 12/1
Nowy Targ; Malopolskie; Postal Code: 34-400

Contact Details: Purchase the Miroslawa Frankowska-Majchrzak I Anna Galica sp. j. report to view the information.

Basic Information
Financial Auditors:
Purchase the Miroslawa Frankowska-Majchrzak I Anna Galica sp. j. report to view the information.
Incorporation Date:
October 02, 2006
Company Performance
Financial values in the chart are available after Miroslawa Frankowska-Majchrzak I Anna Galica sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
5.45%
Total operating revenue
-18.56%
Operating Profit/Loss (EBIT)
-96.18%
EBITDA
-87.64%
Net Profit/Loss for the Period
-96.18%
Total Assets
-39.2%
Total Equity
-72.64%
Operating Profit Margin (ROS)
-21.8%
Net Profit Margin
-21.8%
Return on Equity (ROE)
-64.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?